CONCLUSION In conclusion, vitamin B12 deficiency management involves various administration routes, including intramuscular (IM), oral, and subcutaneous methods
What it is: A once-weekly GLP-1 medicine for chronic weight management when combined with diet and activity How it works: Activates GLP-1 receptors in the brain and gut to reduce hunger and increase fullness What to expect: Many patients see steady weight loss over several months as the dose reaches a maintenance level Common considerations: Nausea, mild stomach discomfort, constipation, or diarrhea can occur during dose increases and usually improve with time and meal adjustments What it is: A once-weekly medicine that targets both GIP and GLP-1 receptors How it works: Adds a second pathway that further supports appetite control and metabolic health What to expect: Clinical studies have shown larger average weight reductions at higher doses compared with GLP-1 alone
The role of GLP-1R in DM is principally to regulate glycemic control by stimulating insulin secretion, inhibiting glucagon secretion, and improving insulin signaling, thereby reducing blood glucose levels
We need encouragement
The data have shown that L-carnitine supplementation significantly scavenge free radicals and protect the cells from oxidative stress [31] by decreasing the serum MDA level and increased activity of catalase, GPX, and SOD enzymes